THE INTERACTIONS BETWEEN SLEEP DISORDERED BREATHING, METABOLIC SYNDROME AND VASCULAR RISK
Recruiting
- Conditions
- Metabolic SyndromeMetabolic and Endocrine - Metabolic disordersRespiratory - Sleep apnoea
- Registration Number
- ACTRN12605000083695
- Lead Sponsor
- Institute for Breathing and Sleep
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
subjects with metabolic syndrome and no known sleep disorders
Exclusion Criteria
No exclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cardiovascular risk factors[Measured at baseline and after 4 months treatment with either sham or active CPAP]
- Secondary Outcome Measures
Name Time Method Diabetes control[Measured at baseline and after 4 months treatment with either sham or active CPAP.]